IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
166 hedge funds and large institutions have $1.34B invested in Impax Laboratories, Inc. in 2013 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
166
Holders Change
+8
Holders Change %
+5.06%
% of All Funds
4.82%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
63
Reduced
60
Closed
21
Calls
$3.98M
Puts
$2.43M
Net Calls
+$1.55M
Net Calls Change
-$846K
Top Buyers
| 1 |
O
OrbiMed
New York
|
$107M |
| 2 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
$11.7M |
| 3 |
Jennison Associates
New York
|
$27.5M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
$13.9M |
| 5 |
Renaissance Technologies
New York
|
$35.4M |
